• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

HIV (Human Immunodeficiency Virus) - Articles and news items

global hiv treatment

Global dual-drug trial aims to advance HIV treatment

Industry news / 16 August 2016 / ViiV Healthcare

ViiV Healthcare is undertaking two identical studies as part of a global phase III programme comparing a two-drug regimen of dolutegravir plus lamivudine, with a three-drug regimen of dolutegravir (Tivicay), plus the fixed-dose tablet tenofovir/emtricitabine (Truvada), to support regulatory filings as a treatment for HIV, for adults who have had no prior antiretroviral therapy…

triumeq

Triumeq demonstrates superior efficacy for treating women with HIV

Industry news / 19 July 2016 / Victoria White, Digital Content Producer

Triumeq demonstrated superior efficacy compared with ATV/r plus TDF/FTC in 495 treatment-naïve women living with HIV…

odefsey

EC grants marketing authorisation to Odefsey in HIV

Industry news / 23 June 2016 / Victoria White, Digital Content Producer

The EC has granted marketing authorisation for Gilead’s once-daily single tablet regimen Odefsey for the treatment of HIV-1 infection in certain patients…

3BNC117

3BNC117 opens door to potential new treatment for HIV

Industry news / 9 May 2016 / Victoria White, Digital Content Producer

Researchers are developing a new kind of treatment, an antibody-based drug called 3BNC117, that may provide a better strategy for long-term control of HIV…

hiv

From HIV to oncology: widening access through flexible IP

Blog, Z Homepage promo / 28 April 2016 / Jon Pender, VP Government Affairs, GSK

Jon Pender, GSK, discusses how a flexible and thoughtful approach to IP can help get medicines to the poorest and hardest-to-reach patients around the world…

descovy

EC grants marketing authorisation for two doses of Gilead’s Descovy

Industry news / 25 April 2016 / Victoria White, Digital Content Producer

Descovy is the first new HIV backbone approved in Europe in more than a decade and represents an important advance in addressing the needs of patients…

HIV-and-HCV

Combined HIV and hepatitis C virus vaccination a step closer

Industry news / 13 April 2016 / Victoria White, Digital Content Producer

A study has shown that the ‘prime boost’ approach is compatible with co-administration of vectors encoding for HIV and HCV antigens…

vrc01

Enrolment begins in trials of investigational anti-HIV antibody VRC01

Industry news / 7 April 2016 / Victoria White, Digital Content Producer

Enrolment has started for two multinational clinical trials of an intravenously delivered investigational antibody for preventing HIV infection, VRC01…

darunavir/cobicistat

NHS England to fund HIV treatment Rezolsta (darunavir/cobicistat)

Industry news / 30 March 2016 / Victoria White

Darunavir/cobicistat is indicated for use in combination with other antiretroviral medications, for treating adults with HIV-1…

latte-2

Janssen announces results from its ongoing LATTE-2 study

Industry news / 26 February 2016 / Victoria White

The LATTE-2 study showed that a regimen of two investigational long-acting, intramuscular (IM) formulations of HIV medicines had comparable antiviral activity to 3-drug oral antiretroviral therapy in HIV-1 infected adults…

descovy

CHMP adopts positive opinion of Gilead’s Descovy

Industry news / 26 February 2016 / Victoria White

Descovy is an investigational fixed-dose combination for the treatment of HIV-1 infection in adults and adolescents in combination with other HIV antiretroviral agents…

hiv-1

Gilead announces results from study evaluating switching to F/TAF-based regimens from Truvada

Industry news / 24 February 2016 / Victoria White

At Week 48 of the study, the F/TAF-based regimens were found to be statistically non-inferior to the F/TDF-based regimens in HIV-1 infected adult patients…

 

Webinar: Different thermal analysis techniques to measure the glass transitionWATCH NOW
+ +